Showing 1 - 8 results of 8 for search 'Rupert Capiña', query time: 0.03s
Refine Results
-
1
Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials by Rayeil J. Chua, Rupert Capiña, Hezhao Ji
Published 2022-06-01
Article -
2
-
3
-
4
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing by Cheryl Jennings, Neil T. Parkin, Daniel J. Zaccaro, Rupert Capina, Paul Sandstrom, Hezhao Ji, Donald J. Brambilla, James W. Bremer
Published 2020-12-01
Article -
5
-
6
HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade. by François Cholette, Jeffrey Joy, Yann Pelcat, Laura H Thompson, Richard Pilon, John Ho, Rupert Capina, Chris Archibald, James F Blanchard, Faran Emmanuel, Tahira Reza, Nosheen Dar, Richard Harrigan, John Kim, Paul Sandstrom
Published 2020-01-01
Article -
7
A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1. by Binhua Liang, Ma Luo, Joel Scott-Herridge, Christina Semeniuk, Mark Mendoza, Rupert Capina, Brent Sheardown, Hezhao Ji, Joshua Kimani, Blake T Ball, Gary Van Domselaar, Morag Graham, Shane Tyler, Steven J M Jones, Francis A Plummer
Published 2011-01-01
Article -
8
HIV-1 clade D is associated with increased rates of CD4 decline in a Kenyan cohort. by Lyle R McKinnon, Nico J Nagelkerke, Rupert Kaul, Souradet Y Shaw, Rupert Capina, Ma Luo, Anthony Kariri, Winnie Apidi, Makobu Kimani, Charles Wachihi, Walter Jaoko, A Omu Anzala, Joshua Kimani, T Blake Ball, Francis A Plummer
Published 2012-01-01
Article